Price
CHART BY
Frequently asked questions
What is Progyny's market capitalization?
The market capitalization of Progyny is €1.51B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Progyny's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Progyny is 34.96. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Progyny?
Progyny's Earnings Per Share (EPS) over the trailing twelve months (TTM) is €0.502. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Progyny's stock?
Currently, 10 analysts cover Progyny's stock, with a consensus target price of €24.06. Analyst ratings provide insights into the stock's expected performance.
What is Progyny's revenue over the trailing twelve months?
Over the trailing twelve months, Progyny reported a revenue of €1.06B.
What is the EBITDA for Progyny?
Progyny's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is €68.81M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Progyny?
Progyny has a free cash flow of €161.99M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Progyny have, and what sector and industry does it belong to?
Progyny employs approximately 680 people. It operates in the Health Care sector, specifically within the Miscellaneous Commercial Services industry.
What is the free float of Progyny's shares?
The free float of Progyny is 71.78M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- €1.51B
- EPS (TTM)
- €0.502
- Free Float
- 71.78M
- P/E ratio (TTM)
- 34.96
- Revenue (TTM)
- €1.06B
- EBITDA (TTM)
- €68.81M
- Free Cashflow (TTM)
- €161.99M
Pricing
- 52W span
- €12.70€25.78
Analyst Ratings
The price target is €24.06 and the stock is covered by 10 analysts.
Buy
5
Hold
5
Sell
0
Information
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm’s network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
- Employees
- 680
- Industries
- Miscellaneous Commercial Services
- Sector
- Health Care
Identifier
- Primary Ticker
- PGNY
Fundamentals & EOD data from FactSet